Of course there are negatives, as with all projects. The main...

Of course there are negatives, as with all projects. The main negative for me is having to raise around $225m AUD for capex mid next year knowing now our MC is currently only $30m. There's still a long time for our SP to appreciate before we need to raise the funds and obviously the more we can borrow the better for current shareholders. The company has been very clear that one of their main goals is to minimize any dilution as this project develops, and I think having Oz as our JV partner will help a lot with financing. The other obvious negative is the remoteness of the deposit.

Re grade, that initially deterred me until I considered how it's actually a not too shabby 1.21% CuEq as a sulphide. And probably the more important point is the scoping study showed that it's on the bottom 1/3 of the C1 cash cost curve - I'm pretty sure we're lower than the Nova deposit, which was eventually sold to Independence Group for $1.8b.